Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Recommended Dosage and Administration of PalbociclibThe standard dosing regimen for Palbociclib is 125 mg once daily for three consecutive weeks, followed by one week off (i.e., 21···【more】
Article source：Captain MedicineRelease date：2026-05-13Recommended：52
In which situations is palbociclib strictly contraindicated?Before starting palbociclib, you must inform your doctor if any of the following apply: First, if you are allergic to pa···【more】
Article source：Captain MedicineRelease date：2026-05-13Recommended：49
What is Palbociclib?Palbociclib is an oral anticancer drug whose active ingredient is palbociclib. It is a targeted therapy specifically used to treat certain types of advanced bre···【more】
Article source：Captain MedicineRelease date：2026-05-13Recommended：50
Palbociclib Dosing Regimen and Monitoring PointsThe standard dosing regimen for palbociclib is 125 mg taken orally once daily for 3 consecutive weeks followed by 1 week off. Tablet···【more】
Article source：Captain MedicineRelease date：2026-05-12Recommended：52
Dietary Considerations for PalbociclibMaintaining good nutrition is essential during treatment for metastatic breast cancer. A well-balanced diet helps the body preserve muscle str···【more】
Article source：Captain MedicineRelease date：2026-05-12Recommended：61
Drug Interactions and Dosage in Hepatic Impairment for PalbociclibPalbociclib is primarily metabolized by CYP3A enzymes. Coadministration with strong CYP3A inhibitors should be avo···【more】
Article source：Captain MedicineRelease date：2026-05-12Recommended：48
Indications and Combination Regimens of PalbociclibPalbociclib 125 mg capsules and tablets are indicated for the treatment of hormone receptor-positive (HR+), human epidermal growt···【more】
Article source：Captain MedicineRelease date：2026-05-12Recommended：49
Semaglutide: Serious Warnings Requiring Immediate Medical AttentionIn rare cases, serious side effects may occur and require close vigilance. Rare (up to 1/1,000): severe allergic ···【more】
Article source：Captain MedicineRelease date：2026-05-11Recommended：68
Starting Dose and Escalation Regimen for SemaglutideSemaglutide must be taken strictly according to your doctor's prescription. The recommended starting dose is one 3 mg tablet···【more】
Article source：Captain MedicineRelease date：2026-05-11Recommended：60
Gastrointestinal Issues and Dehydration Risk with SemaglutideDuring treatment with semaglutide, some patients may experience nausea, vomiting, or diarrhea. These symptoms usually l···【more】
Article source：Captain MedicineRelease date：2026-05-11Recommended：66
Indications for SemaglutideType 2 diabetes is a condition in which the body does not produce enough insulin, or the insulin produced does not effectively lower blood sugar. In some···【more】
Article source：Captain MedicineRelease date：2026-05-11Recommended：70
Serious Side Effects of SemaglutideIn addition to common gastrointestinal reactions, semaglutide tablets may cause some serious side effects requiring emergency medical attention: ···【more】
Article source：Captain MedicineRelease date：2026-05-09Recommended：67
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：3512025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：5522024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：3372025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：3522025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：3272025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：3932025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3272025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：3012025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
